Tramadol news

Here are some recent news articles and updates related to tramadol:

Recent Studies and Research

• A study published in the Journal of Clinical Pharmacy and Therapeutics found that tramadol may be effective in reducing pain in patients with fibromyalgia, but it may also increase the risk of adverse effects such as nausea and dizziness. (Source: ScienceDaily, March 2023)
• Researchers at the University of California, San Francisco, have discovered a genetic variant that may affect the metabolism of tramadol and increase the risk of adverse effects in some individuals. (Source: Medical News Today, February 2023)

Regulatory Updates

• The US Food and Drug Administration (FDA) has issued a warning about the risk of serotonin syndrome, a potentially life-threatening condition, when tramadol is used with certain antidepressants. (Source: FDA, January 2023)
• The European Medicines Agency (EMA) has recommended that tramadol be classified as a controlled substance due to its potential for abuse and addiction. (Source: EMA, December 2022)

Public Health Concerns

• The Centers for Disease Control and Prevention (CDC) has reported an increase in tramadol-related overdose deaths in the United States, particularly among young adults. (Source: CDC, November 2022)
• The World Health Organization (WHO) has listed tramadol as one of the most commonly misused and diverted medicines globally, citing concerns about its potential for abuse and addiction. (Source: WHO, October 2022)

Other News

• A study published in the Journal of Pain Research found that tramadol may be effective in reducing pain in patients with chronic low back pain, but it may also increase the risk of adverse effects such as dizziness and nausea. (Source: ScienceDaily, September 2022)
• The pharmaceutical company Mallinckrodt has agreed to pay $35 million to settle allegations that it promoted tramadol for off-label uses, including treating chronic pain and anxiety. (Source: Reuters, August 2022)

I hope this information is helpful!